135 related articles for article (PubMed ID: 9626659)
1. Divergent pathways regulate ligand-independent activation of ER alpha in SK-N-BE neuroblastoma and COS-1 renal carcinoma cells.
Patrone C; Gianazza E; Santagati S; Agrati P; Maggi A
Mol Endocrinol; 1998 Jun; 12(6):835-41. PubMed ID: 9626659
[TBL] [Abstract][Full Text] [Related]
2. Cross-coupling between insulin and estrogen receptor in human neuroblastoma cells.
Patrone C; Ma ZQ; Pollio G; Agrati P; Parker MG; Maggi A
Mol Endocrinol; 1996 May; 10(5):499-507. PubMed ID: 8732681
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factors activate estrogen receptor to control the growth and differentiation of the human neuroblastoma cell line SK-ER3.
Ma ZQ; Santagati S; Patrone C; Pollio G; Vegeto E; Maggi A
Mol Endocrinol; 1994 Jul; 8(7):910-8. PubMed ID: 7984152
[TBL] [Abstract][Full Text] [Related]
4. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.
Dutertre M; Smith CL
Mol Endocrinol; 2003 Jul; 17(7):1296-314. PubMed ID: 12714702
[TBL] [Abstract][Full Text] [Related]
5. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor.
Migliaccio A; Piccolo D; Castoria G; Di Domenico M; Bilancio A; Lombardi M; Gong W; Beato M; Auricchio F
EMBO J; 1998 Apr; 17(7):2008-18. PubMed ID: 9524123
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rg1 protects against 6-OHDA-induced neurotoxicity in neuroblastoma SK-N-SH cells via IGF-I receptor and estrogen receptor pathways.
Gao QG; Chen WF; Xie JX; Wong MS
J Neurochem; 2009 Jun; 109(5):1338-47. PubMed ID: 19476546
[TBL] [Abstract][Full Text] [Related]
7. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
8. Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation.
Fox EM; Kuba MG; Miller TW; Davies BR; Arteaga CL
Breast Cancer Res; 2013; 15(4):R55. PubMed ID: 23844554
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway.
Feng W; Webb P; Nguyen P; Liu X; Li J; Karin M; Kushner PJ
Mol Endocrinol; 2001 Jan; 15(1):32-45. PubMed ID: 11145737
[TBL] [Abstract][Full Text] [Related]
10. Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha.
Endoh H; Maruyama K; Masuhiro Y; Kobayashi Y; Goto M; Tai H; Yanagisawa J; Metzger D; Hashimoto S; Kato S
Mol Cell Biol; 1999 Aug; 19(8):5363-72. PubMed ID: 10409727
[TBL] [Abstract][Full Text] [Related]
11. Prolonged vs transient roles for early cell cycle signaling components.
Rose DW; Xiao S; Pillay TS; Kolch W; Olefsky JM
Oncogene; 1998 Aug; 17(7):889-99. PubMed ID: 9780005
[TBL] [Abstract][Full Text] [Related]
12. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation.
Bunone G; Briand PA; Miksicek RJ; Picard D
EMBO J; 1996 May; 15(9):2174-83. PubMed ID: 8641283
[TBL] [Abstract][Full Text] [Related]
13. A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer.
Fox EM; Miller TW; Balko JM; Kuba MG; Sánchez V; Smith RA; Liu S; González-Angulo AM; Mills GB; Ye F; Shyr Y; Manning HC; Buck E; Arteaga CL
Cancer Res; 2011 Nov; 71(21):6773-84. PubMed ID: 21908557
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic differences in the activation of estrogen receptor-alpha (ER alpha)- and ER beta-dependent gene expression by cAMP signaling pathway(s).
Coleman KM; Dutertre M; El-Gharbawy A; Rowan BG; Weigel NL; Smith CL
J Biol Chem; 2003 Apr; 278(15):12834-45. PubMed ID: 12566449
[TBL] [Abstract][Full Text] [Related]
15. Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk.
Klotz DM; Hewitt SC; Ciana P; Raviscioni M; Lindzey JK; Foley J; Maggi A; DiAugustine RP; Korach KS
J Biol Chem; 2002 Mar; 277(10):8531-7. PubMed ID: 11751931
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance.
Campbell RA; Bhat-Nakshatri P; Patel NM; Constantinidou D; Ali S; Nakshatri H
J Biol Chem; 2001 Mar; 276(13):9817-24. PubMed ID: 11139588
[TBL] [Abstract][Full Text] [Related]
17. Regulation of GRIP1 and CBP Coactivator activity by Rho GDI modulates estrogen receptor transcriptional enhancement.
Su LF; Wang Z; Garabedian MJ
J Biol Chem; 2002 Oct; 277(40):37037-44. PubMed ID: 12138084
[TBL] [Abstract][Full Text] [Related]
18. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase.
Kato S; Endoh H; Masuhiro Y; Kitamoto T; Uchiyama S; Sasaki H; Masushige S; Gotoh Y; Nishida E; Kawashima H; Metzger D; Chambon P
Science; 1995 Dec; 270(5241):1491-4. PubMed ID: 7491495
[TBL] [Abstract][Full Text] [Related]
19. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.
Bollig A; Miksicek RJ
Mol Endocrinol; 2000 May; 14(5):634-49. PubMed ID: 10809228
[TBL] [Abstract][Full Text] [Related]
20. Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1.
Tremblay A; Tremblay GB; Labrie F; Giguère V
Mol Cell; 1999 Apr; 3(4):513-9. PubMed ID: 10230404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
